A quantitative UHPLC-MS/MS method for the growth hormone-releasing peptide-6 determination in complex biological matrices and transdermal formulations
dc.contributor.author | Esposito, Cloé | |
dc.contributor.author | García Ac, Araceli | |
dc.contributor.author | Laszlo, Elise | |
dc.contributor.author | Duy, Sung Vo | |
dc.contributor.author | Michaud, Catherine | |
dc.contributor.author | Sauvé, Sébastien | |
dc.contributor.author | Ong, Huy | |
dc.contributor.author | Marleau, Sylvie | |
dc.contributor.author | Banquy, Xavier | |
dc.contributor.author | Brambilla, Davide | |
dc.date.accessioned | 2022-12-19T16:28:39Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2022-12-19T16:28:39Z | |
dc.date.issued | 2021-05-26 | |
dc.identifier.uri | http://hdl.handle.net/1866/27298 | |
dc.publisher | Elsevier | fr |
dc.subject | UHPLC-MS/MS | fr |
dc.subject | Plasma | fr |
dc.subject | Transdermal drug delivery | fr |
dc.subject | Skin | fr |
dc.subject | Extraction | fr |
dc.subject | Peptide | fr |
dc.title | A quantitative UHPLC-MS/MS method for the growth hormone-releasing peptide-6 determination in complex biological matrices and transdermal formulations | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de pharmacie | fr |
dc.identifier.doi | 10.1016/j.talanta.2021.122555 | |
dcterms.abstract | Growth hormone-releasing peptide-6 (GHRP-6) is part of a group of small synthetic peptides with potent GH-releasing activity that have gained attention in the last two decades by virtue of their cyto- and cardioprotective effects. Despite numerous preclinical studies highlighting the potential cardiovascular benefits of GHRP-6, confirmation of clinical efficacy is still awaited. Recent advances in transdermal drug delivery systems have been made to address challenges related to the poor skin permeation rate of peptides by using pain-free microneedle (MN) devices. Accordingly, highly sensitive and validated analytical methods are required for the potential clinical translation of MN-based peptides. The ultra-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) methods developed in this study aimed to quantify GHRP-6 in biological matrices (plasma, skin) and dissolving polymeric MNs. UHPLC/MS-MS method detection limits of 0.1, 1.1, 0.9 and 1.5 ng/mL were achieved in neat solution, plasma, MN polymer solution, and skin matrices, respectively. Method validation also involved assessment of precision, accuracy, limits of quantification, linearity of matched calibration curves (R2 > 0.990), extraction recovery, matrix effect, stability studies, selectivity, and carry-over effect. Additionally, quality control samples were analyzed at three concentration levels to determine recovery (85–109%) and accuracy/bias (3.2–14.7%). Intra- and inter-day precision were within the range of acceptance (RSDs of 3.0–13.9% and 0.4–14.5%, respectively). The validity and applicability of such methods were successfully demonstrated for transdermal GHRP-6 delivery using GHRP-6-loaded MN patches applied to pig skin. | fr |
dcterms.alternative | A quantitative UPLC-MS/MS method for the growth hormone-releasing peptide-6 determination in complex biological matrices and transdermal formulations | fr |
dcterms.isPartOf | urn:ISSN:0039-9140 | fr |
dcterms.isPartOf | urn:ISSN:1873-3573 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | A quantitative LC-MS/MS method for the growth hormone-releasing peptide-6 determination in complex biological matrices and transdermal formulations Cloé L. Esposito, Araceli Garcia, Élise Laszlo, Sung Vo Duy, Catherine Michaud, Sébastien Sauvé, Huy Ong, Sylvie Marleau, Xavier Banquy and Davide Brambilla – Talanta 233-122555, 2021 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Talanta | fr |
oaire.citationVolume | 233 | fr |
Fichier·s constituant ce document
Ce document figure dans la ou les collections suivantes
Ce document diffusé sur Papyrus est la propriété exclusive des titulaires des droits d'auteur et est protégé par la Loi sur le droit d'auteur (L.R.C. (1985), ch. C-42). Il peut être utilisé dans le cadre d'une utilisation équitable et non commerciale, à des fins d'étude privée ou de recherche, de critique ou de compte-rendu comme le prévoit la Loi. Pour toute autre utilisation, une autorisation écrite des titulaires des droits d'auteur sera nécessaire.